Finanzen von GP-Act III Acquisition Corp (GPAT)GPATGP-Act III Acquisition Corp

Evaluating the bottom line, GP-Act III Acquisition Corp. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of 4.56%, provide a clear picture of how effectively GPAT converts its operational activities into shareholder value.

In the context of the broader market, GPAT competes directly with industry leaders such as ARCL and CHEC. With a market capitalization of $179.05M, it holds a significant position in the sector. When comparing efficiency, GPAT's gross margin of N/A stands against ARCL's N/A and CHEC's N/A. Such benchmarking helps identify whether GP-Act III Acquisition Corp. is trading at a premium or discount relative to its financial performance.

The financial performance shows a declining trend in net income, with Q2 2026 net income dropping significantly to 290,121, compared to 3,304,297 in Q4 2024. The EPS has also decreased from 0.14 in Q4 2024 to 0.01 in Q2 2026, indicating weakening profitability.